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Graphical Abstract 
Abstract 
Recently, various additive manufacturing (3D printing) approaches have been employed to 
fabricate dressings such as film scaffolds that possess well defined architecture and orientation 
at the micro level. In this study, crosslinked chitosan (CH) based film matrices were prepared 
using 3D printing with genipin (GE) as a crosslinker, with glycerol (GLY) and poly ethylene 
glycol (PEG) as plasticiser. The 3D printed films were functionally characterized (tensile, fluid 
handling, mucoadhesion, drug dissolution, morphological properties and cell viability as well 
physico-chemical characterization using scanning electron microscopy, Fourier transform 
infrared spectroscopy and X-ray diffraction. CH-GE-PEG600 3D printed films having the ratio 
of 1:1 polymer: plasticizer was selected due to their appropriate flexibility. Fourier transform 
infrared results showed intermolecular interaction between CH, GE and PEG which was confirmed 
by X-ray diffraction showing amorphous matrix structure. In vitro mucoadhesion studies of CH-
GE-PEG600 films showed the capability of the 3D printed film to adhere to the epithelial surface.  
Scanning electron microscopy images showed that the surface of the plasticised films were 
smooth indicating content uniformity of CH, GE and PEG whilst micro cracks in unplasticised 
films confirmed their brittle nature. Plasticised films also showed high swelling capacity which 
enhanced water absorption. Cytotoxicity (MTT) assay using human skin fibroblast cell lines 
demonstrated that more than 90% of cells were viable after 48 hours confirming non-toxic nature 
of the 3D printed CH-GE-PEG600 films and therefore promising dressing for chronic wound 
healing applications. 
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1. Introduction 
Skin injuries are common clinical conditions encountered by millions of patients globally and 
can result in morbidity, disability and as well as possible death, with consequent negative 
effects on patients’ social and economic lives (Singer and Clark, 1999)(Fan et al., 
2011)(Schreml et al., 2010). The restoration of skin integrity following an injury remains an 
important consideration in medical practice including settings such as major surgeries and 
accident and emergency wards (Jones and Nelson, 2007). In the past, the main concern of 
wound therapy was to keep the wound bed dry to avoid infection, however, the main objective 
in current wound management is the maintenance of  a balanced moist wound setting which 
allows the wound to heal in a normal manner (Bowler et al., 2001)(Boateng et al., 2008). The 
principle is that a moisture-rich environment helps to promote migration of keratinocytes 
through reinforcing cell movements (Larjava et al., 1993), which ultimately aids in rapid 
wound healing.  
 Wound treatment involves both surgical and non-surgical approaches, with dressings 
being the most commonly employed. The modern dressing approach is to facilitate the wound 
healing process rather than just covering the wound (Morgan, 2002)(Dhivya et al., 2015). 
Therefore common dressings including gauze and plasters have largely been replaced with 
more novel dressings (e.g. films, foams, hydrogels, hydrocolloids) which promote healing via 
controlling wound exudate in a balanced way to prevent its accumulation in the wound bed, 
and simultaneously ensuring the availability of an appropriate amount of moisture, which 
increases the likelihood of optimum skin tissue regeneration with minimum scar formation 
(Cutting, 2010)(Bhargavi and Kumar, 2011)(Sussman, 2010).  
 Dressings such as films are used to treat wounds directly and can also be used to deliver 
drugs such as antimicrobials and anti-inflammatories directly to the wound site, to tackle 
infections and / or pain (Pawar et al., 2013)(Boateng and Catanzano, 2015). Films are generally 
biocompatible and biodegradable and they facilitate application around difficult areas such as 
joints (knees, ankles and elbows) owing to their flexibility mechanical behaviour (Wittaya-
Areekul and Prahsarn, 2006). When applied over the wound, films can also reduce excessive 
production of wound exudate as well as development and progression of infection in the wound 
bed (Ehrenreich and Ruszczak, 2006)(Lee and Mooney, 2012). Furthermore, because films are 
transparent, they allow easy observation of the wound bed without the need for removal, which 
makes them useful for improving patient compliance because of reduced frequency of dressing 
changes.  
 There are various approaches available for the preparation of polymeric films including 
spray coating, solvent casting and 3D printing. In spray coating, droplets of a molten coating 
material are dispersed by spraying over an appropriate surface, to produce a uniform film. 
(Meng et al., 2017)(Pham et al., 2010). Solvent casting involves drying of a polymeric solution 
or gel in a suitable casting container such as Petri dish or plate. Solvent casting is widely used 
owing to the ease of manufacturing and cheaper processing costs (Nunes et al., 2016). 
However, spray coating and solvent casting generally do not have control over functional 
characteristics which affect dressing performance such as porosity and how the pores 
interconnect with each other, as well as the structural geometry.  
Additive manufacturing techniques (such as 3D printing) have been employed to 
fabricate scaffolds (films) as potential dressings, possessing well defined architecture and 
physical orientation (Hafezi et al, 2016). 3D printing typically involves printing of appropriate 
‘inks’ (polymer solutions and bioactive gels) to design biocompatible film scaffolds as an 
advanced alternative to the commonly used solvent evaporated films. The micro-structures of 
the printed films aid material exchange, cell attachment and migration which allow better tissue 
regeneration after injury (Dean et al., 2007)(Liu et al., 2016). Furthermore, compared with 
other methods of fabricating scaffolds (films) (Tong et al., 2016), 3D printing facilitates the 
production of more flexible matrices, possessing pre-determined pore sizes, in a reproducible 
manner, since 3D architectures can be designed using CAD software and printed with the help 
of fully automated 3D printing facilities (Murphy and Atala, 2014)(Blaeser et al., 2013)(Y. 
Zhang et al., 2013). 
Leong and co-workers identified ideal physical characteristics of 3D printed films 
capable of facilitating healthy and optimal tissue regeneration (Leong et al., 2003). Their 
investigation involved use of solid freeform, which has potential to overcome the limitations 
of spray coating and solvent casting and showed that solid freeform designed films satisfied 
most of the macro- and micro-architectural characteristics required for tissue engineering in a 
biomedical setting. Liu and colleagues investigated the effect of 3D bio-printed matrices based 
on sodium alginate and gelatine when applied on full-thickness wounds in an in vivo mice 
model and also observed the histopathological changes that occurred over the course of the 
wound healing progression (Liu et al., 2016). The therapeutic 3D bio-printed matrix consisted 
a gelatine-alginate grid formed of layers with regular sized pores. The authors reported an 
average healing time of 16 ± 1 days for the untreated mice and 14 ± 1 days for the animals 
treated with the 3D printed dressing. Furthermore, histological observations under a 
microscope confirmed better healing performance of the 3D printed scaffold in the treated 
mice. They concluded that the biologically active gelatin-alginate printed dressing accelerated 
the healing process by enhancing formation of granulation and scar tissue. Further, Muwaffak 
and co-workers, produced antimicrobial loaded wound dressings based on polycaprolactone 
using 3D printing and loaded with different metals (copper, silver and zinc) and characterized 
them for physical and antimicrobial properties (Muwaffak et al., 2017). The authors showed 
that the various formulated dressings exhibited a dual release profile with an initial fast release 
over 24 hours followed by a slower release over the next 48 hours. They concluded that the 3D 
scanned and 3D printed scaffolds had the potential for used as personalised wound dressings 
and this is particularly useful in the area of chronic wounds where the biochemical, 
physiological and anatomical aetiology can be complex and varies for different patient groups. 
The current research reports on 3D-printed films comprising chitosan (CH) as film former, 
genipin (GE) as crosslinker with either glycerol (GLY) or polyethylene glycol 600 (PEG) as 
plasticizer, as potential bioadhesive dressing for wound healing purposes. GE has generally 
replaced crosslinkers such as glutaraldehyde due to advantages such as biocompatibility, well 
defined chemistry and being less cytotoxic than glutaraldehyde (Muzzarelli, 2009)(Chiono et al., 
2008). Further, GE is reported to exhibit pharmacological activity including anti-inflammatory 
and antibacterial effect (Winotapun et al., 2013) and these together with the biocompatibility 
make GE relevant for wound healing applications. 
The resulting optimized films have been characterized by scanning electron 
microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, tensile testing, 
mucoadhesion, swelling, drug dissolution profiles as well as cell viability (biocompatibility) 
via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.  
 
2.1 Materials 
Medium molecular weight CH, >75-85% deacetylated) and low molecular weight CH, >75-
85% deacetylated) were obtained from Sigma Aldrich (St. Louis, USA). GE with (98%) was 
purchased from Linchuan Zhixin Biotechnology Co., Ltd., Linchuan. Poly ethylene glycol (400 
and 600 molecular weights), glycerol, glacial acetic acid, fluorescein sodium (FS), MTT 
reagent [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], Triton-X-100 and 
dimethyl sulfoxide were all purchased from Sigma–Aldrich (Gillingham, UK). Sodium 
chloride, potassium chloride, disodium phosphate and monopotassium phosphate were all 
purchased from Fisher Scientific (UK). Dulbecco’s Modified Eagles Medium, fetal bovine 
serum, penicillin, streptomycin and glutamine were all purchased from Gibco (Paisley, UK). 
Human fibroblast cells (ATCC® SCRC1041™) were obtained from American Type Culture 
Collection-ATCC (Manassas, Virginia, USA).  
2.2 Methods 
2.2.1 Preparation of 3D printed films 
Medium molecular weight CH gels at different concentrations (0.5-1% w/v) were initially 
prepared as part of preliminary formulation development and concentration was set at 0.5% 
(w/v) because it did not block the jet dispenser’s nozzle. In order to use higher concentrations 
of CH without blocking the nozzle, low molecular weight CH was employed and gels with 
concentrations between 0.7-1.4 % (w/v) were attempted and eventually, the maximum 
concentration was set at 1.2 % (w/v) because it did not block the jet dispenser’s nozzle. CH 
powder and plasticiser (GLY or PEG) were dissolved in 0.5% v/v acetic acid and allowed to 
stand to allow complete removal of bubbles generated during stirring. Subsequently, 5 ml of  
GE solution (1% w/v) was mixed with the CH solution and stirring continued for a further 30 
minutes to allow complete crosslinking between GE and CH. Once a homogeneous mixture 
was obtained, the gel was poured into a jet dispenser’s (583 Dispenser, Nordson-Asymtek, 
Maastricht, Netherlands) syringe for printing. Once printed, the hydrogels were dried for 24 
hours in an oven (30°C). Moreover, 3D printed films having fluorescein sodium (FS) as model 
drug were fabricated using selected optimised CH gels from preliminary formulation 
development. The FS loaded gels were prepared as above at concentration of CH [1.2% (w/v)], 
PEG600 [1.2% (w/v)] and FS 0.1% (w/v). The resulting FS loaded gel was then poured into 
the jet dispenser’s syringe for printing and the printed gels dried in an oven set to 30°C for 24 
hours.  
2.3 Tensile evaluation 
Tensile behaviour of CH-GE films prepared from various CH gel concentrations, plasticized 
with different concentrations of GLY and PEG were evaluated with a texture analyser (TA HD 
plus, Stable Micro Systems, UK). The films (n = 3) were cut into dumb-bell shapes, attached 
between the instruments tensile grips and stretched at a speed of 2 mm/s till breaking point, 
using a trigger force of 0.049 N. The tensile properties were calculated from the force-time 
plots using relevant equations as previously (Boateng et al, 2009). 
 
2.4 X-ray diffraction  
The physical form of the printed films and pure starting materials was carried out using X-ray 
diffractometry instrument (Bruker AXS GmbH, Karlsure, Germany). In the case of the 
starting materials (CH and GE) the powders were held together using mylar prior to being 
loaded onto the sample cell. The films were cut into four pieces, stacked on top of each other, 
placed on the holder and finally on the sample cell. The instrument settings employed were as 
follows: diffraction angle of 5° to 50° 2θ, step size of 0.04°, voltage of 40 kV, current of 40 
mA, using Cu Kα radiation at a wavelength of 1.54060 Å, and scanning speed set at 0.4 
s/step, in transmission mode.  
2.5 Fourier transform infrared spectroscopy  
Spectra of the films were obtained with the help of a Perkin Elmer (Vatrtwo, Massachusetts, 
USA) Fourier transform infrared spectrophotometer from 450 to 4000 cm-1 over 64 scans on 
average. The Fourier transform infrared spectrometer  was equipped with OMINC® software 
and a diamond universal attenuated total reflection unit. The samples (pure materials and films) 
were placed on the diamond crystal and force applied with the help of a pressure clamp which 
ensured proper contact between the samples and crystal. In all cases, background spectra were 
subtracted prior to analysis to achieve more accurate and reproducible spectral profiles. 
2.6 Scanning electron microscopy  
The surface morphology of the plasticised and unplasticised 3D fabricated films was evaluated 
using a Hitachi SU 8030 scanning electron microscope (Hitachi High Technologies, Krefeld, 
Germany). Small strips of film samples were applied onto aluminium pin-type stubs with the 
help of double-sided adhesive carbon tape and coated with chromium using a Sputter Coater 
(Edwards 188 Sputter Coater S1508). Images were captured at various magnifications at an 
accelerating voltage of 1 kV with the help of i-scan 2000 software.  
 
2.7 Mucoadhesion studies  
Mucoadhesion behaviour of the films was evaluated with the help of a texture analyser as 
described above with gelatin (6.67% w/v) allowed to set in a fridge, used as model mucosal 
substrate. Prior to mucoadhesion testing, 500µl of phosphate buffered saline (PBS) at a pH of 
7.4 was spread evenly over the set gelatin in order to equilibrate the gel surface to simulate 
wound pH. The PBS was prepared by dissolving 8 g of sodium chloride, 0.2 g potassium 
chloride, 1.44 g disodium phosphate, 0.24 g monopotassium phosphate in 800ml of deionised 
water the pH was then adjusted to 7.4 ± 0.1 with sodium hydroxide and then volume made up 
with distilled water to 1 litre (Boateng and Ayensu, 2014). The films were cut into circular 
pieces with diameter of 35 mm to fit the probe dimensions. Using double sided adhesive tape, 
the films (n = 3) were attached to the instrument’s 35mm diameter adhesive probe and lowered 
to make contact with the PBS equilibrated gelatin gel. A trigger force of 0.049 N was applied 
during the testing, with contact time of 60 seconds and the films moved between the probe and 
mucosa surface at a speed of 0.5 mm/s till films were detached. The total work of adhesion 
(WOA), peak of adhesion force (PAF) and cohesiveness were calculated using the instrument 
Exponent 32 software.  
2.8 Swelling (fluid handling) capacity  
The fluid handling ability of the films were assessed by measuring the swelling index of the 
films with time in PBS solution (pH 7.4 ± 0.1) at of 37 ± 0.1°C (Winnicka & Szymańska , 
2015). CH-GE (unplasticized) and CH-GE-PEG (plasticized) films were used for this study. 
Films were cut into pieces, each piece (n = 3) was weighed carefully to obtain an accurate 
weight and immersed in 5 ml of PBS. The weight changes of the swollen films were recorded 
at regular time intervals until 120 minutes. For each time point, the PBS was removed and the 
swollen sample wiped gently with filter paper before weighing to allow an accurate weight of 
the sample to be measured at each time point. The swelling index (capacity) (IS %) was 
calculated with the equation below:  
𝐼𝑆 =
𝑊𝑠 − 𝑊𝑑
𝑊𝑑
 × 100 
Ws is swollen weight, Wd is the initial dry weight 
 
2.9 In vitro drug dissolution studies  
Before the dissolution studies, FS content within the film was analysed. The FS loaded film (n 
= 3) was weighed accurately to 25mg and hydrated in 10 ml of 0.5% (v/v) acetic acid, sonicated 
for 1 hour and then continuously stirred at room temperature to allow complete dissolution of 
the CH. Dissolution studies were performed using glass vials containing 2 ml of PBS (pH 7.4) 
as dissolution medium at 37°C and continuously stirred (200 rpm). The 3D printed films were 
cut, accurately weighed (20–40 mg) and placed in the glass vials containing dissolution 
medium (PBS). Aliquots (1 ml) of the PBS medium was sampled out at 1, 2, 3, 4, 5, 24 and 48 
hours using a syringe and replaced with 1 ml fresh medium to ensure fixed volume. The 
sampled dissolution media were filtered and transferred into HPLC vials and analysed using 
HPLC. The calculated cumulative percentage drug release at each time point was plotted 
against time (n = 3). 
  
2.10 HPLC analysis 
The concentration of FS was analysed using an Agilent 1200 HPLC system with a 
Chemstation® software. A Hichrom H5ODS-3799 column, 5 µm particle size (125 x 4.6 mm) 
and mobile phase comprising acetonitrile, water and trifluoroacetic acid in the ratio 400:595:5 
v/v at a flow rate of 1 ml/min and detection at 254 nm was employed. Injection volume was 20 
µl and media were filtered before each sample run. A calibration curve of pure standards with 
concentration range of 10-50 µg/ml was plotted for FS (R2 > 0.99) and used to calculate drug 
concentration released at each time point. 
 
2.11 In vitro cell viability (MTT) studies 
Human skin fibroblast cells (ATCC® SCRC1041™) were stored in liquid nitrogen tank (-
180ºC) using dimethyl sulfoxide (200 µl in 2 ml media) as a cryopreservative. The frozen cells 
were thawed according to the ATCC recommended protocol and Dulbecco's Modified Eagle's 
Medium (ATCC® 302002™) was used to culture the cells. The cells were incubated in an 
incubator (37°C, 5% CO2) with medium changes every other day up to 7 days until 80-80% 
confluence was reached. Cells were detached by trypsin-EDTA solution based on the 
recommended ATCC procedure. Before cell seeding, the printed film dressings were sterilized 
using a flow cabinet (NU-437-300E, NUAIRE) with UV light turned on for about 12 hours and 
transferred into 96 well plates. Cell suspension for the experiment was prepared at 
concentration of 1 x 105 cells/ml and aliquots (100 μl) transferred into 96-well microtiter plates 
containing the films. 10 µl of MTT solution prepared in PBS (5 mg/ml) was added to the wells 
containing the samples and placed in an incubator over a 4 hour period. After the 4 hours of 
incubation, the supernatant was siphoned off and then dimethyl sulfoxide (100 µl) was added 
to the wells for dissolving the blue formazan crystals, formed from the MTT due to the 
succinate dehydrogenase within the cells’ mitochondria. The absorbance of the resulting 
solution was determined at 492 nm with the help of a Microplate Reader. Further, the films 
alone were assayed as background controls to rule out contribution of absorbance arising from 
the pure polymers. The final MTT results were based on the average of three replicates (n = 3) 
for each sample tested. The percentage cell viability was calculated by the following equation:  
Cell viability (%) =  
At−Ab
Ac−Ab
∗ 100 
Where At, Ab and Ac are the absorbance of tested samples, medium only and untreated cells, 
respectively. In this experiment, the untreated cells and Triton-X-100 (0.01% w/v) treated 
cells were used as negative (100% viable) and positive controls respectively. 
 
3. Result and discussion  
3.1 3D printing of films by jet dispenser 
The jet dispenser employed in the current study uses a ball-tip at the end of a pneumatic piston 
to guide the polymer based ink (CH-GE gel) through the small orifice at the tip of the jet nozzle. 
The piston is lifted by air pressure, causing the polymer solution to move round the piston to 
enter the nozzle. The piston is returned to the nozzle tip by pressure in the spring upon removal 
of the air pressure. Once the ball tip makes contact with the nozzle seat, the fluid is activated 
which leads to the ejection of droplets from the tip of the jet. Several interacting drops of fluid 
can be deposited at the same position to achieve a much bigger dot. The approach described 
above has the capability to deposit several drops, up to one hundred per second (Scoutaris et 
al., 2016). The size of the droplet is controlled by different parameters including the holes of 
the nozzle, seat and ball tip size, the pressure of the fluid being printed and stroke length. In 
this study, a 400 micron nozzle was selected to enable dispensing of large amounts of the 
viscous printing gels (inks) with high reproducibility. 
  CH-GE gels at different concentrations (0.5-1.4% w/v) were initially formulated and 
the optimum concentration of 1.2% (w/v) was selected because it did not block nozzle of the 
jet dispenser and resulted in films with optimum mechanical properties among all the 
formulations prepared. There was a need for a plasticizer due to film’s brittleness, however, 
plasticizer effect on the film performance was quantified using texture analysis as outlined 
below.  
 
3.2 Texture analysis (TA) 
As noted above, one of the most important characteristics of film based dressings include the 
ability to easily apply to difficult areas such as elbows and hips (Boateng et al., 2009). 
Generally, biopolymers employed to fabricate wound dressings possess weak mechanical 
strength and ease of use by patients and carers since which therefore limits their potential for 
use within a clinical setting (Vieira et al., 2011) and therefore require use of plasticizers. 
Plasticizers are essential in polymeric films and wound dressings because of their ability to 
enhance the flexibility of polymers via lowering the glass transition temperature (Karki et al., 
2016).  
Fig. 1 and Fig. 2 show for tensile profiles (strength, elastic modulus and elongation at 
break) for CH-GE, CH-GE-GLY (different ratios of CH: GLY) and CH-GE-PEG (different 
ratios of CH: PEG and different molecular weight grades of PEG (400, 600). Unplasticized 
CH-GE 3D printed films showed low percentage elongation at break (2.44%) which indicates 
high brittleness and for that reason not suitable to be applied as a dressing for wound healing 
applications. Therefore, PEG and GLY were incorporated to improve the flexibility of the 3D 
printed films. Plasticisers such as GLY and PEG act by interfering with hydrogen bond 
interaction between the polymer chains, due to its highly hydrophilic characteristics, and as a 
result decrease the inter molecular forces. This leads to enlargement of the spaces between the 
polymer chains which reduces the brittleness and promotes flexibility as well as increase in the 
thickness of the films (Vieira et al., 2011). 
For CH-GE-GLY films, there was an inverse relationship between the concentration of 
GLY and the tensile strength and elastic modulus and a directly proportional relationship with 
the elongation at break. Fig. 1 showed that 3D printed films at CH: GLY ratios of 4:1 and 2:1 
had a higher elongation at break in comparison with unplasticized CH-GE film. However, such 
high amount of GLY can result in accumulation of exudate or highly wet conditions which 
could result in skin maceration around the wound area which is a risk factor, clinically, that 
could result in complications such as infection and ultimately become chronic (Karbowiak et 
al., 2006)(Boateng et al., 2009). 
In CH-GE-PEG 3D printed films (Fig. 2), a similar relationship between the 
concentration of PEG and the tensile properties was observed as was the case for GLY. Another 
study by Tanaka and co-workers confirmed that increasing the concentration of plasticizer 
resulted in a lower tensile strength value with a corresponding increase in the values for percent 
elongation (Tanaka et al., 2001). 
Suyatma and colleagues (Suyatma et al., 2005) investigated the tensile characteristics 
of CH films in the presence of plasticiser (PEG and GLY) and showed that plasticization 
improved the CH film ductility. As shown in Fig. 2, CH-GE-PEG600 3D printed films having 
the ratio of 1:1 of CH: PEG had the highest value of elongation at break (22.67%) which made 
them an ideal film with a balance between flexibility and toughness (not sticky) among all the 
other fabricated 3D printed films and was the formulation of choice for further characterization 
and drug loading.    
  
3.3 X-ray diffraction (XRD) 
Fig. 3 shows the X-ray diffraction patterns of the starting compounds (CH and GE) along with 
the selected optimised 3D printed films (CH-GE-PEG600). The diffractogram of CH exhibited 
no high intensity peaks which shows its amorphous structure. On the other hand, GE showed 
high crystallinity as was expected with sharp high intensity peaks (Fig. 3b). The X-ray 
diffractograms for CH-GE-PEG600 films showed just one broad peak at 14° and another peak 
at 20° 2θ attributed to mylar. This suggests the amorphous nature of the films, which indicates 
that GE is molecularly dispersed within the 3D printed polymer matrix (Desai and Park, 2005) 
and also shows that GE and CH were successfully crosslinked. Zhang and co reported on how 
different concentration ratios of GE and silk fibroin: (CH) affected the formation of SF–CH 
microspheres (Zhang et al., 2013). They investigated the X-ray diffraction patterns of CH, GE, 
silk fibroin, BSA and CH-GE together and confirmed the amorphous nature of CH as well as 
the crystalline nature of GE. 
 
3.4 Fourier transform infrared spectroscopy  
Fig. 4 shows Fourier transform infrared spectra of the starting materials and 3D printed 
scaffolds. The spectra of CH showed three characteristic bands at 3370 cm-1, 1659 cm-1 and 
1575 cm-1 attributed to the –OH stretching vibration which is generally due to water molecules, 
–NH2 from the amide group I (C=O), and amide group II respectively (Lambert et al., 1987). 
There is an overlap of stretching vibrations from the amine (N-H) functional group at 3289 cm-
1 (Klein et al., 2016). The spectrum of GE showed three characteristic bands at 989, 1088, and 
1622 cm−1, assigned to the C-H ring out-of-plane bend, C-H ring in-plane bend, and C=C 
double bond ring stretch modes of the core of the molecule, respectively (Arteche et al., 2013). 
Additionally, the C-O-C asymmetric stretch and the CH3 bend of the methyl ester was observed 
at 1300 and 1443 cm−1, respectively. Other researchers reported similar Fourier transform 
infrared spectra for CH and GE pure compounds (Azevedo et al., 2006)(Bhattarai et al., 
2005)(Delgadillo-Armendariz et al., 2014)(Li et al., 2009). 
The crosslinking of CH with GE involves a fast reaction in which the amino group of 
CH makes a nucleophilic attack at the olefinic C-3 atom of GE resulting in the opening of the 
dihydropyran ring and ultimately in a tertiary amine derivative of GE linked to a glucosamine 
unit, being formed (Klein et al., 2016). In addition, a slower reaction involving the generation 
of an amide takes place via a reaction involving the amino group on CH and ester group (by 
C-11) of GE (Mi et al., 2001). The amide II band observed at 1550 cm-1, which is characteristic 
of N–H deformation (Lambert et al., 1987), could be attributed to the formation of secondary 
amides due to the latter reaction between the ester and hydroxyl groups of GE and the amino 
groups of CH. Pure PEG showed peaks at 1105, 947, and 817 cm-1 (Bhattarai et al., 2005) but 
for the CH-GE-PEG 3D printed films, the hydroxyl, amino and amide groups of CH shifted 
slightly (3370 cm-1  to 3330 cm-1 for hydroxyl, 1659 cm-1 to 1650 cm-1 for amino group and 
from 1575 cm-1 to 1550 cm-1 for amide group) due to crosslinking while their intensities 
decreased due to grafting of PEG (Klein et al., 2016). In comparison to the peak at 1652 cm-1 
for the amide I peak, the intensity of amide II  peak at 1550 cm-1 showed a decrease suggesting 
that the –NH2 groups of CH were linked with the PEG chains (Kolhe & Kannan, 2003). 
 
3.5 Scanning electron microscopy  
Scanning electron microscopy images of unplasticized (CH-GE) and plasticized (CH-GE-
PEG600) 3D printed films with different magnifications are shown in Fig. 5. The CH-GE films 
displayed a smooth surface with a homogeneous and dense structure without appearance of any 
pores on the film surface. This is a good indication that the GE was homogeneously distributed 
within the composite 3D printed film scaffolds. However, a few cracks were visible on the 
surface of unplasticized film which is possibly due to absence of plasticiser (PEG) within the 
formulations. It can also be observed that the unplasticised films showed a tightly packed 
matrix architecture which resulted in micro-cracking observed on the film surface (Liu et al., 
2013) which confirmed the previous observations from the tensile results that the unplasticised 
films were brittle in nature. The plasticized 3D printed films exhibited smooth surfaces with 
no visible cracks as expected, indicating content uniformity of CH, GE and PEG. This is mainly 
due to presence of PEG as the plasticizing agent which reduces the tensile strength while 
significantly increasing the percent elongation. Such flexibility is ideal to reduce the chances 
of causing further injury to the healing tissue. This is particularly true in the case of orthopaedic 
wounds, which are susceptible to inflammation and swelling and therefore likely to experience 
friction between the wound bed and the applied dressing (Ousey et al., 2011) and such friction 
can cause significant pain to the patient. Similar studies by Vieira and co-workers (Vieira et 
al., 2011) as well as by Suyatma and co (Suyatma et al., 2005) were performed and similar 
results were reported. 
 
3.6 Mucoadhesion studies by texture analyser 
Fig. 6 shows PAF, cohesiveness and WOA of plasticized and unplasticized 3D printed films 
after detachment from the PBS equilibrated gelatin surface. The plasticized 3D printed films 
(CH-GE-PEG600) showed a high PAF of (3.05±0.56) and WOA (1.986±0.17) compared to 
unplasticized films (CH-GE) which had a PAF of (2.7±0.34) and WOA (1.81±0.2). This could 
be attributed to the effect of PEG as plasticizer which is in agreement with previously reported 
studies (Morales and McConville, 2011)(Karki et al., 2016) who reported that the incorporation 
of a plasticizer enhances the mucoadhesive properties. PEG can function by enhancing 
adhesion through improvement in the hydrogen bonding interaction between the polymeric 
chain and the model mucosal chains thereby improving mucoadhesion performance (Yadav et 
al., 2010) and this can be explained by the diffusion theory of mucoadhesion (Yu et al., 2014). 
Moreover, plasticized films hydrate better, which is important during the initial stages of 
mucoadhesion, with hydration enhancing chain inter penetration between the polymeric chains 
and those of the model mucosal surface, leading to higher detachment force of the films. The 
high adhesion of the plasticised films implies they will most likely remain longer when applied 
on the wound surface and therefore potentially reduce the need for regular changes of applied 
dressing which causes patient non-compliance as a result of pain experienced during dressing 
removal. 
 
3.7 Swelling (fluid handling) studies 
Swelling studies were performed in order to simulate the ability of the 3D printed film scaffolds 
to adequately handle wound fluid (exudate), using an in vitro model. It is very important to 
adequately select the medium prior to the swelling studies. Studies were carried out using PBS 
at pH 7.4 to mimic wound exudate on the surface of the wound. (Szymańska and Winnicka, 
2015). PBS is the most commonly used swelling medium to simulate wounds during testing of 
dressing behaviour.  Fig. 7 shows the swelling profiles of the unplasticized (CH-GE) and (CH-
GE-PEG) films with time. The maximum swelling capacity of the CH-GE films was 940±99% 
which was increased to 985±165% for the corresponding plasticised films (CH-GE-PEG600). 
It was observed that for both films, swelling increased rapidly within the first 5 minutes while 
maintaining their structural integrity in PBS. However, the films began to lose their integrity 
after the 30 minutes after which swelling capacity decreased gradually for both films until a 
steady state was reached at 80 minutes for CH-GE and 90 minutes for CH-GE-PEG600.  
It can be observed from the results that the plasticized films swelled to a higher extent 
in comparison with the unplasticized films. Plasticizer increases the spaces between the 
polymeric chains and this permits better ingress of water to occupy these inter chain spaces and 
hence increases rate of hydration which enhances swelling capacity (Roy and Prabhakar, 
2010)(Azevedo et al., 2006). Furthermore, CH-GE-PEG600 exhibited lower levels of 
crystallinity because of favourable interactions between the constituent starting materials. This 
results in better diffusion of PBS into the films providing a higher swelling ratio (Liu et al., 
2012). Further, the swelling capacity of CH-GE-PEG600 films also increased because of the 
PEG’s hydrophilicity. Liu and colleagues showed that the molecular weight of PEG affected 
the swelling capacity of CH-GE-PEG films (Liu et al., 2012). The higher the molecular weight, 
the higher the swelling ratio of CH-GE-PEG film. Their results indicated that films plasticised 
with low molecular weight PEG exhibited the lowest swelling, because of the higher miscibility 
with CH which was efficient in protecting the PEG from rapid hydration in PBS. The high 
ability of CH-GE-PEG films to swell makes them suitable for use as absorbent dressings. This 
makes them ideal for managing exudate by absorbing and retaining excess wound fluid, 
preventing it from damaging the newly formed wound tissue and the surrounding healthy skin, 
whilst at the same time allowing an appropriate amount of moisture within the wound bed to 
facilitate cell migration and proliferation. 
  
3.8 In vitro drug dissolution studies 
CH provides several advantages for topical drug delivery including bioadhesion, 
biocompatibility and non-irritancy and antimicrobial action against certain bacteria (Muzzarelli 
et al., 2015). The in vitro drug release profile in PBS for CH-GE-PEG600 films loaded with 
FS is shown in Fig. 8. Almost 67% release was achieved within the first hour and 62.72% after 
2 hours. Furthermore, the % release decreased slightly between 5 hours and 24 hours. After 24 
hours the % release decreased further to 40.21% at 48 hours suggesting possible FS degradation 
in the dissolution medium with time. Compounds of intermediate polarity (e.g. doxorubicin 
and FS) were difficult to entrap because of their solubility in the bilayer and surrounding 
aqueous media (Niesman et al., 1992). FS was used at this stage of the formulation 
development as cheap model soluble drug to help with the design of an optimum 3D printed 
scaffold able to deliver therapeutic agents directly to a chronic wound site to allow the dressing 
to take active part in the wound healing process. The in vitro drug dissolution profile matched 
that observed in the swelling study, with rapid initial hydration of the dressing observed within 
15 minutes and resulting in rapid release, within the first hour. This confirms that drug release 
is dependent on initial swelling of the 3D printed film, followed by diffusion of the FS from 
the swollen polymeric film and possibly via matrix disintegration into the dissolution medium. 
The drug release profile differs from results reported by Muwaffak and co-workers, using 3D 
printed polycaprolactone films, where  a dual release profile was observed, with an initial fast 
release over 24 hours followed by a slower release over the next 48 hours (Muwaffak et al., 
2017). In a study by Liu and co-workers, it was shown that CH-GE-PEG films with porous 
micro structure were able to control the rate at which drug was released from the matrix due to 
sequential dissolution of PEG  (Liu et al., 2012). This is because when the water soluble PEG 
dissolves it results in formation of pores in the structure which accelerate the release of the 
drug from the swollen film that remains. On the other hand, it has been reported that 
crosslinking can prolong the duration of the release over a longer period. This is because the 
addition of GE (crosslinker) to the matrix resulted in hydrogel formation possessing a 
permanent network structure, due to formation of irreversible chemical links which delays 
rapid erosion via disintegration and ensures slower drug release due to slower rate of diffusion 
through the structured matrix.  
In an ideal drug delivery dressing, the release of drug over a longer period of 24 to 48 
hours is generally helpful for the patient as it avoids  the need to remove the dressing frequently. 
However, Fig. 8 shows that the CH-GE-PEG films did not control the release of the drug 
compared to the reported studies described above. This is because in this study, we used a 
highly soluble fluorescent dye which dissolves and diffuses very rapidly from the swollen 
dressing matrix and therefore further formulation development will be required in the future 
using active ingredients with intermediate to low solubility, which will be expected to afford 
more controlled drug release. Nevertheless, the number of the times that a dressing needs 
changing is affected by other factors including type of the wound, its size, the amount of the 
exudate and depth of the wound (Boateng et al., 2008).   
 
3.9 MTT studies 
MTT was used to evaluate the effect of the optimized CH-GE-PEG600 3D printed films on 
viability of human fibroblast cells (105 cells/ml) at 24 and 48 hours respectively. Fig. 9 shows 
the MTT results of 3D printed films after 24 and 48 hours of incubation. After 24 hours, 97.38% 
of the human fibroblast cells were viable while more than 90% were viable after 48 hours. 
Based on the ISO guidelines for medical devices and biomaterials, for materials such as wound 
dressing to be accepted as biocompatible, the cell viability after exposure should be ≥ 70% 
(Moritz et al., 2014). The results clearly show that the CH-GE-PEG600 3D printed films are 
biocompatible with human fibroblast cells with cell viability values greater than 70%, and 
expected not to cause any skin irritation or interfere with cell proliferation. This is not 
surprising since CH is a known safe material approved for use in several biomedical and 
pharmaceutical formulations such as moist wound dressings (Patrulea et al., 2015). Zhang and 
co-authors (Zhang et al., 2008) and Ribeiro and co-authors  (Ribeiro et al., 2009) investigated 
CH/PEG diacrylate films and CH hydrogels cytoxicity respectively and concluded that CH 
exerted no acute toxicity. 
 
4. Conclusion 
3D printing was employed for the preparation film based dressings comprising CH, GE and 
PEG for potential wound healing applications and facilitated the fabrication of wound dressing 
scaffolds having control over geometry and interconnectivity. The GE crosslinked CH gels 
were deposited layer upon layer using jet dispenser to provide a fine 3D printed dressing. CH-
GE-PEG600 3D printed films having the ratio of 1:1 polymer: plasticizer was selected due to 
their relatively high flexibility essential for easy application. Fourier transform infrared 
characterization of the 3D printed dressings showed inter molecular interaction between CH, 
GE and PEG confirming the crosslinking. In vitro mucoadhesion studies of CH-GE-PEG600 
films showed the capability of the 3D printed film to adhere to the model mucosal surface. 
Further, swelling and in vitro drug release using FS as model drug showed that the crosslinked 
printed film was able to swell and release the model drug which is useful for managing wound 
exudate, maintain a moist environment whilst providing appropriate therapeutic drug doses 
within a reasonable time frame. Cytotoxicity assay (MTT) demonstrated that more than 90% 
of cells were viable after 48 hours which shows that the 3D printed CH-GE-PEG600 films are 
not toxic and therefore biocompatible with human skin and should not interfere with cell 
proliferation when applied to a wound. In conclusion, 3D printed CH-GE films seem to be 
promising dressing for potential chronic wound healing application. Future studies will involve 
more advanced wound healing characterization using active ingredients more specific to the 
wound healing process. 
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Figure 1 Elastic modulus, tensile strength and elongation at break for 3D printed CH-GE, 
CH-GE-GLY films (n = 3, ± SD) 
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Figure 2 Tensile (elastic modulus, tensile strength and elongation at break) properties of 3D printed CH-GE-PEG600 films (n=3, ± SD) 
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Figure 3 X-ray diffractograms of a) pure CH, b) pure GE, and c) 3D printed CH-GE-PEG600 9 
films 10 
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Figure 4 FTIR spectra of pure starting materials (CH, GE, PEG) and CH-GE-PEG600 3D 15 
printed film 16 
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Figure 5 CH-GE and CH-GE-PEG600 3D printed film at magnifications of a) 40, b) 250, c) 31 
2000 and d) 5000 32 
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Figure 6. Mucoadhesion profiles of CH-GE and CH-GE-PEG600 3D printed films (n = 3, ± 39 
SD) 40 
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 46 
Figure 7 Swelling profiles showing the change in the % swelling index with time of CH-GE 47 
and CH-GE-PEG600 3D printed films (n=3, ±SD) 48 
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 53 
Figure 8 Drug dissolution profile of FS loaded CH-GE-FS-PEG600 3D printed films (n=3, 54 
±SD) in PBS at pH 7.4 55 
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 61 
Figure 9 Cytotoxicity (MTT) analysis of the CH-GE-PEG600 3D printed films with untreated 62 
cells as negative control and Triton-X -100 as toxic positive control (n=3, ±SD) 63 
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